Cleveland Clinic Medical Dermatology Therapy Update III 2024
Include: 22 videos + 1 pdf, size: 13.2 GB
Target Audience: physicians, residents, fellows, allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine
Information:
Medical Dermatology Therapy Update III
Autoimmune, Chronic Inflammatory, and Advanced Malignant Diseases
Attend this CME-certified educational activity for a unique opportunity to update your knowledge
and understanding of both traditional and new therapeutic strategies for a range of critically
important medical dermatologic conditions, including rheumatology-dermatology overlap
diseases, atopic dermatitis, advanced melanoma and other cutaneous malignancies, urticaria,
sarcoidosis, hidradenitis suppurativa, autoimmune bullous disease, cutaneous lymphomas, alopecia areata, and psoriatic disease.
By Participating, You Will Be Able To:
- Describe the cutaneous manifestations of rheumatological disorders in medical dermatology and their burden, and provide updates in their medical therapy updates and optimization.
- Summarize updates in therapeutic strategies and critically appraise the safety and efficacy of topical, biologic and small molecule therapies for managing medical dermatological diseases.
- Describe updates in the treatment of atopic dermatitis, psoriatic arthritis and psoriatic vulgaris.
- Provide updates in the medical treatment of advanced cutaneous malignancies, autoimmune blistering diseases and granulomatous diseases.
- Summarize strategies to optimize an interprofessional team approach to caring for patients with complex medical dermatologic diseases.
Who Should Attend?
This course is designed for physicians, pharmacists, nurses, nurse practitioners, physician assistants, residents, fellows and allied health professionals in dermatology, immunology, oncology, rheumatology, internal medicine, family medicine, and general practice.
Topics:
- Agenda.pdf
- Day 1 Present and Future Insights into the Pathogenesis of Cancer-Associated Dermatomyositis.mp4
- Day 1 Present and Future Insights into the Pathogenesis of Cutaneous Lupus Erythematosus.mp4
- Day 1 The Story of Extracorporeal Photopheresis.mp4
- Day 1 The Story of Subacute Cutaneous Lupus Erythematosus and Amyopathic Dermatomyositis.mp4
- Day 1 Update in Treatment of Cutaneous Lupus Erythematosus.mp4
- Day 1 Update in Treatment of Cutaneous Vasculitis.mp4
- Day 1 Update in Treatment of Fibrosing Skin Diseases.mp4
- Day 2 Collaborative Strategies to Manage Patients on Major Systemic Medications Lessons Learned from Isotreinoin.mp4
- Day 2 Communicating for Influence.mp4
- Day 2 Present State and Future of Medical Dermatology Insights from Tenures as Editor-in-Chief of the JAAD and AAD President.mp4
- Day 2 Shared Medical Appointments – a Team Approach to Improve Access and Patient Experience.mp4
- Day 2 Update in Treatment of Chronic Urticaria.mp4
- Day 2 Update in Treatment of Hidradenitis Suppurativa.mp4
- Day 2 Update in Treatment of Inflammatory Alopecias.mp4
- Day 2 Update in Treatment of Psoriasis Vulgaris.mp4
- Day 2 Update in Treatment of Psoriatic Arthritis.mp4
- Day 3 Artificial Intelligence in Medical Dermatology.mp4
- Day 3 Update in Treatment of Advanced Non-Melanoma Skin Cancers.mp4
- Day 3 Update in Treatment of Autoimmune Bullous Diseases.mp4
- Day 3 Update in Treatment of Cutaneous irAEs Related to Cancer Immunotherapies.mp4
- Day 3 Update in Treatment of Cutaneous T-cell Lymphomas.mp4
- Day 3 Update in Treatment of Sarcoidosis and Granulomatous Diseases.mp4
